Start | Browse by Day | Author Index

219 What is the evidence for the FDA warning for intravenous haloperidol and QT interval prolongation ?

Sunday, April 26, 2009
Carla Meyer-Massetti, MSc , University of California San Francisco, San Francisco, CA
Christine M Cheng, PharmD , University of California San Francisco, San Francisco, CA
B Joseph Guglielmo, PharmD , University of California San Francisco, San Francisco, CA
See more of: Scientific Poster Presentations Session Two
See more of: Residents and Fellows Research in Progress
<< Previous Abstract | Next Abstract >>